Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
Kresse is an experienced operating executive with a proven track record driving high growth across both private and public technology companies Infleqtion (the "Company"), a global leader in neutral atom-based quantum computing and quantum sensing, powered by neutral-atom technology, announced the appointment of Dave Kresse as Vice President of Commercial Solutions, effective immediately. Kresse brings more than 30 years of experience building and scaling technology businesses, leading global teams and forging commercial partnerships. He joins Infleqtion after the company announced in September that it plans to go public through a business combination with Churchill Capital Corp X (NASDAQ
Microchip Technology CFO brings decades of public-company finance and governance experience Infleqtion, a global leader in quantum sensing and quantum computing powered by neutral-atom technology, announced the appointment of J. Eric Bjornholt to its Board of Directors effective immediately. Bjornholt brings more than three decades of finance and advisory experience, joining Infleqtion as the Company advances toward its planned public listing. The company announced in September that it plans to go public through a business combination with Churchill Capital Corp X (NASDAQ:CCCX) ("Churchill X"), a special purpose acquisition company. Bjornholt currently serves as Chief Financial Officer
Infleqtion, a global leader in quantum sensing and quantum computing powered by neutral-atom technology, today announced that its joint registration statement on Form S-4 (the "Registration Statement") with Churchill Capital Corp X (NASDAQ:CCCX) ("Churchill X"), filed with Securities and Exchange Commission (the "SEC") in connection with the proposed business combination between Infleqtion and Churchill X, was declared effective by the SEC on January 23, 2026. This represents an important step in the process toward completion of the previously disclosed proposed business combination between Infleqtion and Churchill X. Churchill X has set a meeting date of February 12, 2026 for its extraordi
3 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)
3 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)
425 - Churchill Capital Corp X/Cayman (0002007825) (Subject)
425 - Churchill Capital Corp X/Cayman (0002007825) (Subject)
EFFECT - Churchill Capital Corp X/Cayman (0002007825) (Filer)